Skip to main content
profile image
Selected Works of Carlo B. Bifulco, M.D.
Article
Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Clinical Trials (2019)
  • Rom Leidner, EACRI - Providence Cancer Center, Portland, OR;
  • R. Bryan Bell, EACRI - Providence Cancer Center, Portland, OR;
  • Kristina Young, EACRI - Providence Cancer Center, Portland, OR;
  • Brendan Curti, EACRI - Providence Cancer Center, Portland, OR;
  • Marcus Couey, EACRI - Providence Cancer Center, Portland, OR;
  • Ashish Patel, Providence Cancer Institute, Portland, OR.
  • Amber Watters, Providence Cancer Institute, Portland, OR.
  • Hong Xiao, Providence Cancer Institute, Portland, OR.
  • Carlo Bifulco, EACRI - Providence Cancer Center, Portland, OR;
  • Brian Piening, EACRI - Providence Cancer Center, Portland, OR;
  • George Morris, Providence Cancer Institute, Portland, OR.
  • Lessli Rushforth, Providence Cancer Institute, Portland, OR.
  • Dawn Brucker, Providence Cancer Institute, Portland, OR.
  • Shorin Nemeth, Providence Cancer Institute, Portland, OR.
  • Michael Gough, EACRI - Providence Cancer Center, Portland, OR;
  • Marka Crittenden, EACRI - Providence Cancer Center, Portland, OR;
Link
Disciplines
Publication Date
July 1, 2019
DOI
10.1158/1538-7445.AM2019-CT182
Citation Information
Rom Leidner, R. Bryan Bell, Kristina Young, Brendan Curti, et al.. "Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection" Clinical Trials Vol. 79 (2019)
Available at: http://works.bepress.com/carlo-bifulco/65/